Buy Rating Reiterated as Atebimetinib’s Combination Potential and Astellas Collaboration Support $14 Price Target
at www.tipranks.com (Thu, 12-Nov 11:25 AM)
Immuneering Appoints Grant C. Bogle to Board of Directors
at www.tipranks.com (Mon, 9-Nov 5:34 PM)
H.C. Wainwright Reaffirms Their Buy Rating on Immuneering (IMRX)
at www.tipranks.com (Mon, 9-Nov 6:35 AM)
